Editorial: New vaccines and drugs for human microbial infections
Frontiers in Microbiology · 09.04.2026 · 17
DOI: 10.3389/fmicb.2026.1837270 ↗Kurz gefasst
Editorial in der Zeitschrift Frontiers in Microbiology, online erschienen am 09.04.2026. Verfasst von Pedro José Alcolea und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biological Research Centre Margarita Salas, Spanish Research Council (CIB-CSIC), Madrid, Spain. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
detailing the history of anthrax vaccine development and the transition toward secondgeneration recombinant subunit vaccines currently under testing.Two of the Reviews, the first being systematic, compile the state-of-the-art on vaccine development against a bacterial and a viral infection, respectively, whereas the third one focuses on topical treatment formulations to combat multidrug-resistant (MDR) pathogenic bacteria.In their Systematic Review, Taha et al.(https://doi.org/10.3389/fmicb.2024.1385834) present a meta-analysis of five randomized controlled clinical trials that evaluated the safety and immunogenicity of the Vi-DT vaccine, a diphtheria toxoid-conjugated typhoid vaccine, in children under two years old. The vaccine showed a robust safety profile with just quickly resolved mild to moderate adverse events and comparable seroconversion to the WHO-prequalified Vi-TT vaccine, as well as a stronger immune memory response. Vi-DT is a safe, effective, and potentially cost-beneficial prophylactic tool against typhoid fever, caused by Salmonella typhi, a public health threat particularly associated with poor sanitation conditions. In conclusion, these nine studies fulfil the aims of these Research Topic, spanning from the discovery to the review of novel treatment and vaccine strategies. To continue addressing these global health challenges, a second volume of this topic will be shortly issued, providing a continued platform for cutting-edge research in the field.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biological Research Centre Margarita Salas, Spanish Research Council (CIB-CSIC), Madrid, Spain.
- Special Infectious Agents Unit BSL-3, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
- Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Zitieren
APA
Alcolea, P. J., Alonso, A., & Alandijany, T. A. (2026). Editorial: New vaccines and drugs for human microbial infections. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1837270
Vancouver
Alcolea PJ, Alonso A, Alandijany TA. Editorial: New vaccines and drugs for human microbial infections. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1837270
BibTeX
@article{Alcolea2026,
author = {Alcolea, Pedro José and Alonso, Ana and Alandijany, Thamir A},
title = {Editorial: New vaccines and drugs for human microbial infections},
journal = {Frontiers in Microbiology},
year = {2026},
volume = {17},
doi = {10.3389/fmicb.2026.1837270}
}
EUVIMED